Neu2000KWL

Developed for: cardiac arrest · cerebral infarction · ischemic stroke
Investigated by: GNT Pharma · Beijing Tiantan Hospital · Chonnam National University Hospital · Daqing Oil Field Hospital · First Affiliated Hospital of Jinan University · First Affiliated Hospital of Wenzhou Medical University
+37 more
· First Affiliated Hospital of Zhejiang University · First Hospital of China Medical University · Gangnam Severance Hospital · General Hospital of Shenyang Military Region · Guangzhou First People's Hospital · Hebei General Hospital · Hebei Medical University Third Hospital · Inner Mongolia Baogang Hospital · Kyungpook National University Hospital · Nanfang Hospital, Southern Medical University · Nanjing PLA General Hospital · Peking University First Hospital · Peking University Third Hospital · Pusan National University Hospital · Qilu Hospital of Shandong University · Samsung Medical Center · Second Affiliated Hospital of Guangzhou Medical University · Second Affiliated Hospital, School of Medicine, Zhejiang University · Second Hospital of Shanxi Medical University · Shandong Provincial Hospital · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai Minhang Central Hospital · Shanghai Pudong New Area People's Hospital · Soonchunhyang University Hospital · Subei People's Hospital of Jiangsu Province · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · The Central Hospital of Lishui City · The First Affiliated Hospital of BaoTou Medical College · The First Affiliated Hospital of Soochow University · The First Hospital of Jilin University · The Second Hospital of Hebei Medical University · Tianjin First Central Hospital · Tianjin Huanhu Hospital · Tongji Hospital · Xiangya Hospital of Central South University · Xuanwu Hospital, Beijing · Zhejiang Apeloa Jiayuan Pharmaceutical Co. Ltd.

Trials 3

today NCT03651557 · Ph 2 NCT04486430 · Ph 2 NCT02831088 · Ph 2

20172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT03651557	Nov 2018 → May 2021	cardiac arrest	GNT Pharma	Unknown	Missed primary
Phase 2	NCT04486430	Mar 2017 → Jun 2019	cerebral infarction	Beijing Tiantan Hospital	Completed	No outcome recorded
Phase 2	NCT02831088	Jul 2016 → Dec 2018	ischemic stroke	GNT Pharma	Unknown	Missed primary

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	Neu2000KWL	“Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset” NCT04486430 ↗ 2 NCT03651557 ↗ NCT02831088 ↗
Action	Inhibit	“It selectively blocks N-methyl-D-aspartate receptors and scavenges for free radicals.” PMID 30005644 ↗ Jul 2018
Route	Intravenous	“Neu2000KWL showed promising safety profiles without any serious adverse events up to a single intravenous infusion of 6000 mg” NCT02831088 ↗